Evidence map›Paper›PMID 24661203›Full record

ReviewBritish journal of pharmacology2015

Gas what: NO is not the only answer to sexual function.

G Yetik-Anacak, R Sorrentino, A E Linder, N Murat

Open access · hybridAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A Synthetic Supramolecular Receptor for the Hydrosulfide Anion.Angewandte Chemie (International ed. in English) · 2016
    Article
  13. Article
  14. Article
  15. Safety and efficacy of low intensity shockwave (LISW) treatment in patients with erectile dysfunction.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

G Yetik-AnacakDepartment of Pharmacology, Faculty of Pharmacy, Ege University, İzmir, Turkey.
R Sorrentino
A E Linder
N Murat
Dokuz Eylül University · TREge University · TRUniversidade Federal de Santa Catarina · BRUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability to get and keep an erection is important to men for several reasons and the inability is known as erectile dysfunction (ED). ED has started to be accepted as an early indicator of systemic endothelial dysfunction and subsequently of cardiovascular diseases. The role of NO in endothelial relaxation and erectile function is well accepted. The discovery of NO as a small signalling gasotransmitter led to the investigation of the role of other endogenously derived gases, carbon monoxide (CO) and hydrogen sulphide (H2 S) in physiological and pathophysiological conditions. The role of NO and CO in sexual function and dysfunction has been investigated more extensively and, recently, the involvement of H2 S in erectile function has also been confirmed. In this review, we focus on the role of these three sister gasotransmitters in the physiology, pharmacology and pathophysiology of sexual function in man, specifically erectile function. We have also reviewed the role of soluble guanylyl cyclase/cGMP pathway as a common target of these gasotransmitters. Several studies have proposed alternative therapies targeting different mechanisms in addition to PDE-5 inhibition for ED treatment, since some patients do not respond to these drugs. This review highlights complementary and possible coordinated roles for these mediators and treatments targeting these gasotransmitters in erectile function/ED.

Indexed as

AnimalsCarbon MonoxideCyclic GMPDrug DesignErectile DysfunctionGuanylate CyclaseHumansHydrogen SulfideMaleMolecular Targeted TherapyNitric OxidePenile ErectionReceptors, Cytoplasmic and NuclearSignal TransductionSoluble Guanylyl CyclaseCarbon MonoxideCyclic GMPGuanylate CyclaseHydrogen SulfideNitric OxideReceptors, Cytoplasmic and NuclearSoluble Guanylyl Cyclase

Identifiers

PMID24661203
PMCPMC4369255
OpenAlexW1549387216

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.